2D Layered Double Hydroxide Nanoparticles: Recent Progress toward Preclinical/Clinical NanomedicineZhenbang Cao, Zi Gu, Bei Li et al.|Small Methods|2019Cited by 150
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)Yuankai Shi, Luyao Sun, Airong Wang et al.|癌症：英文版|2022Cited by 60
Targeted Drug Delivery: 2D Layered Double Hydroxide Nanoparticles: Recent Progress toward Preclinical/Clinical Nanomedicine (Small Methods 2/2020)Zhenbang Cao, Zi Gu, Bei Li et al.|Small Methods|2020Cited by 6